Blair, M. Diabetes mellitus review. Urol. Nurs. 36, 27–36 (2016).
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43, S14–S31 (2020).
International Diabetes Federation. IDF Diabetes Atlas 10thEdition https://diabetesatlas.org/data/en/ (2021).
Carracher, A. M., Marathe, P. H. & Close, K. L. International diabetes federation 2017. J. Diabetes 10, 353–356 (2018).
Gregg, E. W., Sattar, N. & Ali, M. K. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4, 537–547 (2016).
Kalofoutis, C. et al. Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Exp. Clin. Cardiol. 12, 17–28 (2007).
CAS PubMed PubMed Central Google Scholar
Chawla, A., Chawla, R. & Jaggi, S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J. Endocrinol. Metab. 2, 546–551 (2016).
Malik, S. et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245–1250 (2004).
Shah, A. D. et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 3, 105–113 (2015).
Article PubMed PubMed Central Google Scholar
Emerging Risk Factors Collaboration et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215 (2010).
Coles, B. et al. Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population. J. Diabetes Investig. 12, 1175–1182 (2021).
Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease. The Framingham study. J. Am. Med. Assoc. 241, 2035–2038 (1979).
Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937–952 (2004).
de Jong, M., Woodward, M. & Peters, S. A. E. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: a prospective cohort study of the UK Biobank. Diabetes Care 43, 2050–2059 (2020).
Liu, L., Simon, B., Shi, J., Mallhi, A. K. & Eisen, H. J. Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: evidence on health outcomes and antidiabetic treatment in United States adults. World J. Diabetes 7, 449–461 (2016).
Article PubMed PubMed Central Google Scholar
Malmborg, M. et al. Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? Eur. Heart J. 41, 1346–1353 (2020).
Suh, D. C., Choi, I. S., Plauschinat, C., Kwon, J. & Baron, M. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988–1994 to 1999–2004. J. Diabetes Complicat. 24, 382–391 (2010).
World Health Organization. Obesity and Overweight https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (2021).
Bhupathiraju, S. N. & Hu, F. B. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ. Res. 118, 1723–1735 (2016).
Article CAS PubMed PubMed Central Google Scholar
Taylor, R., Al-Mrabeh, A. & Sattar, N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 7, 726–736 (2019).
Article CAS PubMed Google Scholar
Després, J. P. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 28, 1039–1049 (2008).
Huang, L. H., Liao, Y. L. & Hsu, C. H. Waist circumference is a better predictor than body mass index of insulin resistance in type 2 diabetes. Obes. Res. Clin. Pract. 6, e263–e346 (2012).
Hajian-Tilaki, K. & Heidari, B. Is waist circumference a better predictor of diabetes than body mass index or waist-to-height ratio in Iranian adults? Int. J. Prev. Med. 6, 5 (2015).
Article PubMed PubMed Central Google Scholar
Peters, S. A. E., Bots, S. H. & Woodward, M. Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK biobank. J. Am. Heart Assoc. 7, e008507 (2018).
Article PubMed PubMed Central Google Scholar
Martín-Timón, I., Sevillano-Collantes, C., Segura-Galindo, A. & Del Cañizo-Gómez, F. J. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J. Diabetes 5, 444–470 (2014).
Article PubMed PubMed Central Google Scholar
Sone, H. et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J. Clin. Endocrinol. Metab. 96, 3448–3456 (2011).
Article CAS PubMed Google Scholar
Fan, W., Philip, S., Granowitz, C., Toth, P. P. & Wong, N. D. Residual hypertriglyceridemia and estimated atherosclerotic cardiovascular disease risk by statin use in US adults with diabetes: National Health and Nutrition Examination Survey 2007–2014. Diabetes Care 42, 2307–2314 (2019).
Katakami, N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J. Atheroscler. Thromb. 25, 27–39 (2018).
Article CAS PubMed PubMed Central Google Scholar
Rizvi, A. A. Addressing hypertension in the patient with type 2 diabetes mellitus: pathogenesis, goals, and therapeutic approach. Eur. Med. J. Diabetes 5, 84–92 (2017).
PubMed PubMed Central Google Scholar
Song, Y. et al. Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999–2012. Sci. Rep. 6, 36093 (2016).
Article CAS PubMed PubMed Central Google Scholar
Long, A. N. & Dagogo-Jack, S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J. Clin. Hypertens. 13, 244–251 (2011).
Li, M. et al. Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the China cardiometabolic disease and cancer cohort (4C) study. Diabetes Care 43, 1929–1936 (2020).
Zhang, Y. et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia 63, 21–33 (2020).
Patterson, R. et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur. J. Epidemiol. 33, 811–829 (2018).
Article PubMed PubMed Central Google Scholar
Schwab, U., Reynolds, A. N., Sallinen, T., Rivellese, A. A. & Riserus, U. Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis. Eur. J. Nutr. 60, 3355–3363 (2021).
Article CAS PubMed Google Scholar
Hirahatake, K. M. et al. Diet quality and cardiovascular disease risk in postmenopausal women with type 2 diabetes mellitus: the women’s health initiative. J. Am. Heart Assoc. 8, e013249 (2019).
Article PubMed PubMed Central Google Scholar
Hirahatake, K. M. et al. Cumulative intake of artificially sweetened and sugar-sweetened beverages and risk of incident type 2 diabetes in young adults: the coronary artery risk development in young adults (CARDIA) study. Am. J. Clin. Nutr. 110, 733–741 (2019).
Article PubMed PubMed Central Google Scholar
Micha, R. et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. J. Am. Med. Assoc. 317, 912–924 (2017).
Han, T. S. & Lean, M. E. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc. Dis. 5, 2048004016633371 (2016).
PubMed PubMed Central Google Scholar
Welsh, C. et al. Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK biobank. Diabetes Care 43, 440–445 (2020).
Article CAS PubMed Google Scholar
Shah, S. et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun. 11, 163 (2020).
留言 (0)